Bio-Science Laboratories   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Bozeman MT United States (1991)

Organization Overview

First Clinical Trial
1991
NCT00000488
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

BioScience Laboratories | Bioscience Laboratories Inc. | BioScience Laboratories, Inc. | BIOSCIENCE LAB ORA TORIES, INC. | BIOSCIENCE LABORATORIES, INC. | BSLI

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 3)

Coronary Disease (Phase 3)

Death, Sudden (Phase 3)

Death, Sudden, Cardiac (Phase 3)

Heart Diseases (Phase 3)

Ischemia (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Surgical Wound Infection (Phase 2)

Ventricular Fibrillation (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 14